Sign In
Buy CNMD
$35.16
+0.0300 (+0.0854%)
At Close: Jun 05, 2026
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now
09:55am, Friday, 29'th Nov 2024
CNMD is poised for growth on the back of strong product offerings and recurring revenues but faces headwinds from regulatory challenges, supply-chain constraints and cybersecurity risks.
Here's Why Conmed (CNMD) is a Strong Value Stock
10:40am, Wednesday, 27'th Nov 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Conmed (CNMD) is a Top Growth Stock for the Long-Term
10:50am, Monday, 25'th Nov 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
CONMED Corporation to Participate in a Fireside Chat at the Piper Sandler Healthcare Conference
04:05pm, Monday, 18'th Nov 2024
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, Todd W. Garner, Executive Vice President and Chief Financial
Conmed (CNMD) is a Top-Ranked Momentum Stock: Should You Buy?
10:51am, Friday, 15'th Nov 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Conmed (CNMD) is a Top Value Stock for the Long-Term
10:41am, Monday, 11'th Nov 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Conmed (CNMD) is a Strong Growth Stock
10:46am, Friday, 08'th Nov 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
CONMED Beats on Q3 Earnings, Misses on Sales, Lowers '24 Sales View
09:46am, Thursday, 31'st Oct 2024
CNMD's Q3 earnings beat estimates on the back of higher revenues and lower costs and expenses.
CONMED Corporation (CNMD) Q3 2024 Earnings Call Transcript
09:21pm, Wednesday, 30'th Oct 2024
CONMED Corporation (NYSE:CNMD ) Q3 2024 Earnings Conference Call October 30, 2024 4:30 PM ET Company Participants Curt Hartman – Chairman, President and Chief Executive Officer Pat Beyer – Chief O
Conmed (CNMD) Reports Q3 Earnings: What Key Metrics Have to Say
08:01pm, Wednesday, 30'th Oct 2024
The headline numbers for Conmed (CNMD) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estim
Conmed (CNMD) Surpasses Q3 Earnings Estimates
07:21pm, Wednesday, 30'th Oct 2024
Conmed (CNMD) came out with quarterly earnings of $1.05 per share, beating the Zacks Consensus Estimate of $0.99 per share. This compares to earnings of $0.90 per share a year ago.
CONMED Corporation Announces Third Quarter 2024 Financial Results
04:05pm, Wednesday, 30'th Oct 2024
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Highlights Sales of $316.7 million in
CONMED Corporation Announces Leadership Succession
04:02pm, Wednesday, 30'th Oct 2024
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman will retire as President and Chief Executive Officer (CEO) of the Company, effective January 1, 2025.
Conmed (CNMD) Earnings Expected to Grow: Should You Buy?
11:07am, Wednesday, 23'rd Oct 2024
Conmed (CNMD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Conmed (CNMD) is a Strong Growth Stock
10:46am, Wednesday, 23'rd Oct 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
